PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 2, 2024PLoS ONE27 citationsOpen Access

Global incidence and mortality of childhood leukemia and its relationship with the Human Development Index

View Full Paper
AMAbdollah Mohammadian-HafshejaniIFI.M. FarberSKSoleiman Kheiri

Key Points

Key points are not available for this paper at this time.

Abstract

Background Childhood leukemia (CL) is a major global concern, accounting for 33% of all new cancer cases and 31% of all cancer deaths in children aged 0–14 years. Our study aimed to analyze the global incidence and mortality rates of CL in 2020 and its relationship with the Human Development Index (HDI). Material and methods In this ecologic study, we analyzed the 2020 cancer incidence and mortality data for children aged 0–14 years from the GLOBOCAN Project. We calculated the Age-Standardized Incidence Rate (ASIR) and Age-Standardized Mortality Rate (ASMR) of CL per 100,000 individuals. Pearson’s correlation coefficient was used to examine the association between childhood leukemia ASIR, ASMR, and the HDI, with a statistical significance threshold of P<0.05. Results In 2020, there were a total of 67,008 new cases of CL worldwide, with males accounting for 57.85%. The global ASIR for CL was 3.4 per 100,000 (3.9 in males, 3 in females). Additionally, there were 25,080 CL-related deaths, with males comprising 58.86%. The overall ASMR for CL was 1.3 (1.4 in males, 1.1 in females). We found a significant positive correlation (r = 0.405, P≤0.001) between the global ASIR and ASMR for CL. There was a strong positive correlation (r = 0.770, P = 0.001) between the HDI and childhood leukemia ASIR, but no significant association (r = 0.077, P = 0.337) was observed with ASMR. Conclusion Our study reveals that CL remains a significant health burden worldwide. We identified a positive correlation between the ASIR of CL and the HDI, indicating a potential role of socioeconomic factors in CL incidence.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mohammadian-Hafshejani et al. (2024) studied this question.

synapsesocial.com/papers/68e61927b6db6435875ac42chttps://doi.org/10.1371/journal.pone.0304354
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global, regional, and national epidemiology of leukemia in children from 1990 to 2021: A cross-sectional study2026
  2. 2The global and regional burden of leukemia from 1990-2023: A systematic analysis for the Global Burden of Disease study 2023.2026
  3. 3The global burden of childhood and adolescent leukaemia and attributable risk factors: An analysis of the Global Burden of Disease Study 20192024 · 6 citations
  4. 4Global, regional, and national burdens of leukemia from 1990 to 2019: A systematic analysis of the global burden of disease in 2019 based on the <scp>APC</scp> model2024 · 4 citations
  5. 5Global trends in leukemia incidence by age, sex, and sociodemographic index: A GBD 2023 Joinpoint analysis, 2000–2023.2026